Authors

Joshua Seidman PhD

Portrait of Joshua Seidman PhD

Dr. Seidman leads the Meaningful Use Division in the Office of the National Coordinator for Health Information Technology (ONC) at the U.S. Department of Health and Human Services. In this role, Seidman works to evolve meaningful use practice and policy; help providers become meaningful users of health IT through ONC’s Regional Extension Center Program; and oversee ONC’s e-Quality Measurement agenda.

During two decades in health care, Dr. Seidman has focused on quality measurement and improvement; the intersection of e-health and health services research; and structuring consumer e-health interventions to support improved health behaviors and informed decision making. Previously, Dr. Seidman was the founding President of the Center for Information Therapy, which advanced the practice and science of using health IT to deliver tailored information to consumers to help them make better health decisions. At the IxCenter, Seidman focused on stimulating innovation, diffusing best practices, and evangelizing for a patient-centered orientation to implementation of health IT applications.

Dr. Seidman has also served as Director of Measure Development at the National Committee for Quality Assurance and has done research and analysis related to providers at the American College of Cardiology and the Advisory Board Company.

Seidman earned a Ph.D. in Health Services Research and an M.H.S. in Health Policy & Management from Johns Hopkins School of Public Health. He has a B.A. in Political Science from Brown University.

Joshua Seidman PhD's Latest Blog Posts

Joint Hearing to Conceptualize Clinical Quality for Meaningful Use Stage 3

Joshua Seidman PhD | June 19, 2012

Recognizing the importance of evolving quality concepts within the Electronic Health Record (EHR) Incentive Programs, two ONC federal advisory committee workgroups jointly held a full day hearing on June 7, 2012 to identify ways in which Meaningful Use Stage 3 may advance the consistent delivery of high quality care in diverse care settings. Experts from health care delivery organizations, quality improvement organizations, industry, and academia shared insights regarding how clinical decision support,

Read Full Post.

Federal Advisory Committees Seeking Input on Incorporation of Patient-Generated Data for Stage 3 Meaningful Use

Joshua Seidman PhD | June 18, 2012

ONC’s federal advisory committees (FACAs) held a full-day hearing on June 8 (written testimony can be found here) to explore how patient-generated health data (PGHD) might be incorporated into Meaningful Use (MU) of EHRs for Stage 3 of the EHR Incentive Programs. Some examples of PGHD are data from a patient’s personal health record, data from a blood glucose monitor, or information about a patient’s functional status. Three FACA workgroups hosted the hearing: The Health IT Policy Committee’s MU and Quality Measurement Workgroups,

Read Full Post.

Public Input Shaped the Guiding Principles for Stage 2 Meaningful Use NPRM

Joshua Seidman PhD | March 27, 2012

The Department of Health and Human Services (HHS) recently released two notices of proposed rulemaking (NPRMs) related to Stage 2 of the Medicare and Medicaid EHR Incentive Programs that detail proposed Meaningful Use requirements for providers and the Standards & Certification Criteria (S&CC) that delineate proposed requirements for certified EHR products. The vast majority of the proposed criteria derive from the two federal advisory committees that have been lauded as a model for public,

Read Full Post.

Guiding Principles for Stage 1 Meaningful Use Adjustments

Joshua Seidman PhD | July 30, 2010

The release of the CMS Medicare & Medicaid EHR Incentive Program Final Rule [link] on July 14 marked the end of the Stage 1 process for defining “meaningful use.” The final steps of that process involved reviewing, synthesizing, analyzing and reacting to more than 2,200 comments received from the public. The comments addressed big-picture principles and arcane details, and just about everything in between. We were very grateful for the public input and are very excited to announce the Stage 1 Meaningful Use requirements.

Read Full Post.